Orion
67.45 EUR
+1.05 %
14,337 following
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orion
| Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26e | Q2/26e | Q3/26e | Q4/26e | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 354.9 | 416.5 | 422.8 | 695.3 | 1,889.5 | 403.7 | 477.3 | 484.2 | 575.9 |
| EBITDA | 91.5 | 118.6 | 135.2 | 344.2 | 689.5 | 119.9 | 155.9 | 176.8 | 242.1 |
| EBIT (adj.) | 77.9 | 104.6 | 121.0 | 328.1 | 631.6 | 107.1 | 143.0 | 163.9 | 229.2 |
| EBIT | 77.9 | 104.6 | 121.0 | 328.1 | 631.6 | 107.1 | 143.0 | 163.9 | 229.2 |
| EBIT-% (adj.) | 21.9 % | 25.1 % | 28.6 % | 47.2 % | 33.4 % | 26.5 % | 30.0 % | 33.9 % | 39.8 % |
| EBIT-% | 21.9 % | 25.1 % | 28.6 % | 47.2 % | 33.4 % | 26.5 % | 30.0 % | 33.9 % | 39.8 % |
| Profit before taxes | 76.9 | 103.4 | 120.4 | 327.0 | 627.7 | 106.1 | 142.0 | 162.9 | 228.2 |
| Net income | 61.3 | 82.5 | 96.0 | 260.4 | 500.2 | 83.6 | 112.0 | 128.5 | 180.1 |